Skip to main content

Table 1 Baseline characteristics of AVPM patients by treatment group

From: Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM

Characteristic

Treatment group

 

p-value

 

cFSRT (n = 35)

hSRT (n = 13)

 

MRI Findings before treatment

   

 Optic nerve sheath involved (including ONSM)/Not involved

22/13 (63%/37%)

6/7 (46%/54%)

0.297

 Multiple masses

6 (18%)

1 (8%)

0.655

 Radiographic laterality of tumor (right side)

16 (46%)

6 (46%)

0.978

Histopathologic classification (WHO Grade)

   

WHO Grade

   

 Unknown

9 (56%)

4 (40%)

0.840

  I

6 (38%)

5 (50%)

 

  II

1 (6%)

1 (10%)

 

  III

0 (0%)

0 (0%)

 
  1. AVPM anterior visual pathway meningioma; hSRT hypofractionated stereotactic radiotherapy; cFSRT conventionally fractionated stereotactic radiotherapy; inv. involvement; ONSM optic nerve sheath meningioma. WHO world health organization